Risk of COVID-19 for patients with cancer.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 32142622)

Published in Lancet Oncol on March 03, 2020

Authors

Yang Xia1, Rui Jin1, Jing Zhao2, Wen Li1, Huahao Shen3

Author Affiliations

1: Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
2: Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
3: Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China. Electronic address: huahaoshen@zju.edu.cn.

Associated clinical trials:

COVID19-hematological Malignancies: the Italian Hematology Alliance | NCT04352556

Articles citing this

Challenges posed by COVID-19 to children with cancer. Lancet Oncol (2020) 0.75

Articles cited by this

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol (2020) 18.57